The Maharashtra FDA suspended the food business license of Zepto's parent company citing serious violations of food safety ...

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations (autoinjector, prefilled syringe, and single-dose vial) of ...

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology ...

PR Newswire CHICAGO, May 23, 2025 CHICAGO Generic Pharmaceuticals Market size is projected to be valued at USD 391.5 billion in 2023 and r ...

NICE Actimize, a NICE business, today announced its information-packed agenda for ENGAGE 2025, the industry's premier financial crime and compliance industry event. To be held on June 17-18 at New ...

In some cases, counterfeit drugs have landed people in the hospital, including three people in the United States whose blood ...

"The FDA approval of our third product, mNEXSPIKE, adds an important new tool to help protect people at high risk of severe disease from COVID-19," CEO Stephane Bancel said in the statement.

Nanotechnology is being explored to improve crop tolerance to drought and heat. By enhancing water use, nutrient delivery, ...

NEW DELHI, (Reuters) -The drug company Viatris announced on December 23 that the U.S. Food and Drug Administration (FDA) has restricted ... manufacturing sites in India that produce a wide range ...

Zepto's food business license in Dharavi, Mumbai, has been suspended by the Maharashtra FDA for non-compliance with food ...

The US FDA agency with their designated investigator inspected the facility from May 14-17. The inspection established that the site is in an “Acceptable State of Compliance” with Zero Form ...

Faced with suspension order, Zepto released a statement and said they have already initiated an internal review and are ...